AFP and Cirrhosis: Compared with the non-GT 3 group, patients with GT 3 were with younger age, lower PLT, higher AFP, higher FIB-4, higher APRI scores, increased risk of baseline cirrhosis and HCV reoccurrence (P<0.05; Table 1).